L'intérêt à découvert pour Community Health Sys donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Community Health Sys. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Community Health Sys (NYSE:CYH) Stock, Rapport sur les intérêts à découvert

Community Health Sys

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Community Health Systems

UBS analyst A.J. Rice maintains Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) with a Neutral and lowers the price target from $3.5 to $3.2.

News

Price Target

Analyst Ratings

UBS Maintains Neutral on Community Health Sys, Lowers Price Target to $3.2

RBC Capital analyst Ben Hendrix maintains Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) with a Outperform and lowers the price target from $6 to $5.

RBC Capital Maintains Outperform on Community Health Sys, Lowers Price Target to $5

<h3>Gainers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock rose 74.6% to $0.04 during Thursday's regular session. The market value of their outstanding shares is at $10.2 million. </li>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) stock moved upwards by 41.51% to $0.69. The company's market cap stands at $24.9 million. </li>
<li>X4 Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) stock increased by 31.25% to $1.97. The company's market cap stands at $10.7 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) stock increased by 30.6% to $8.45. The market value of their outstanding shares is at $170.5 million. </li>
<li>West Pharmaceutical Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) shares increased by 20.77% to $274.53. The company's market cap stands at $16.3 billion. The company's, Q2 earnings came out today. </li>
<li>Sensus Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) shares moved upwards by 19.49% to $5.64. The market value of their outstanding shares is at $77.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) stock decreased by 27.6% to $2.81 during Thursday's regular session. The market value of their outstanding shares is at $544.3 million. As per the press release, Q2 earnings came out yesterday. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) stock decreased by 19.15% to $1.52. The market value of their outstanding shares is at $10.0 million. </li>
<li>Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) shares fell 18.51% to $10.86. The company's market cap stands at $1.3 billion. </li>
<li>NovoCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) stock declined by 16.84% to $13.73. The company's market cap stands at $1.8 billion. As per the press release, Q2 earnings came out today. </li>
<li>Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) stock decreased by 15.24% to $3.37. The market value of their outstanding shares is at $1.3 billion. </li>
<li>Apollomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLM#NASDAQ">APLM</a>) shares fell 14.41% to $5.11. The market value of their outstanding shares is at $6.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

APLM

HCTI

IOVA

LIMN

NVCR

PLRZ

PSTV

SRPT

SRTS

XFOR

12 Health Care Stocks Moving In Thursday's Intraday Session

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 200 points on Thursday.
The Dow traded down 0.51% to 44,779.97 while the NASDAQ rose 0.11% to 21,044.05. The S&amp;P 500 also rose, gaining, 0.12% to 6,366.84.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46599936/top-2-tech-stocks-you-may-want-to-dump-this-quarter">Top 2 Tech Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Communication services shares jumped by 1% on Thursday.
In trading on Thursday, consumer discretionary stocks dipped by 1.1%.
Top Headline
Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) reported better-than-expected second-quarter financial results and increased its investment in capital expenditures in 2025. Google parent
Alphabet reported second-quarter revenue of $96.43 billion, beating analyst estimates of $93.72 billion. The company reported second-quarter earnings of $2.31 per share, beating estimates of $2.16 per share.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>AEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) shares shot up 175% to $3.1100 after the company announced its Apollo lidar has been integrated by NVIDIA into the DRIVE AGX platform.</li>
<li>Shares of West Pharmaceutical Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) got a boost, surging 21% to $275.33 after raising FY25 EPS and sales guidance above estimates.</li>
<li>reAlpha Tech Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) shares were also up, gaining 44% to $0.5157 after the company announced that it has repaid in full the outstanding balance on its secured promissory note with Streeterville Capital.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>LKQ Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) shares dropped 21% to $30.35 after the company reported worse-than-expected second-quarter adjusted EPS results and cut its FY25 GAAP EPS and adjusted EPS guidance below estimates.</li>
<li>Shares of Sadot Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDOT#NASDAQ">SDOT</a>) were down 29% to $1.11 as the company announced the pricing of public offering.</li>
<li>Community Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) was down, falling 30% to $2.7150 following second-quarter results.</li>
</ul>
Commodities In commodity news, oil traded up 1.1% to $66.01 while gold traded down 0.5% at $3,380.00.
Silver traded down 0.5% to $39.310 on Thursday, while copper rose 0.5% to $5.8465.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.24%, while Spain's IBEX 35 Index rose 1.28%. London's FTSE 100 gained 1%, Germany's DAX 40 rose 0.11% and France's CAC 40 fell 0.46% during the session.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 surging 1.59%, Hong Kong's Hang Seng gaining 0.51%, China's Shanghai Composite gaining 0.65% and India's BSE Sensex falling 0.66%.
Economics
<ul class="wp-block-list">
<li>The S&amp;P Global manufacturing PMI declined to 49.5 in July, down from market estimates of 52.6.</li>
<li>U.S. initial jobless claims declined by 4,000 from the previous week to 217,000 in the third week of July, compared to market estimates of 227,000.</li>
<li>U.S. building permits fell by 0.1% to an annualized rate of 1.393 million in June.</li>
<li>U.S. natural-gas stocks rose 23 billion cubic feet in the week ending July 18.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46600695/alphabet-to-rally-around-24-here-are-10-top-analyst-forecasts-for-thursday">Alphabet To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Thursday</a></li>
</ul>
Photo via Shutterstock

Earnings

Equities

Eurozone

Intraday Update

Markets

Trading Ideas

AIRE

GOOG

GOOGL

LIDR

SDOT

Crude Oil Rises Over 1%; Alphabet Earnings Top Estimates

WIIM

Community Health Systems shares are trading lower following Q2 reported financial results. Additionally, Jefferies downgraded the stock from Buy to Hold and cut its price target from $4.25 to $3 while Barclays cut its price target from $4 to $3.5.

U.S. stocks traded mixed this morning, with the Dow Jones index falling more than 300 points on Thursday.
Following the market opening Thursday, the Dow traded down 0.68% to 44,702.76 while the NASDAQ rose 0.23% to 21,067.57. The S&amp;P 500 also rose, gaining, 0.08% to 6,363.79.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46599936/top-2-tech-stocks-you-may-want-to-dump-this-quarter">Top 2 Tech Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Communication services shares jumped by 0.9% on Thursday.
In trading on Thursday, consumer discretionary stocks dipped by 1.3%.
Top Headline
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) reported weaker-than-expected second-quarter financial results after market close Wednesday.
Tesla reported second-quarter revenue of $22.5 billion, down 12% year-over-year. The revenue missed a Street consensus estimate of $22.8 billion according to data from Benzinga Pro. Tesla's earnings per share were $0.40 in the quarter, missing the Street consensus estimate of $0.42 per share.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>AEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) shares shot up 245% to $3.95 after the company announced its Apollo lidar has been integrated by NVIDIA into the DRIVE AGX platform.</li>
<li>Shares of Garden Stage Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSIW#NASDAQ">GSIW</a>) got a boost, surging 81% to $0.3187.</li>
<li>reAlpha Tech Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) shares were also up, gaining 41% to $0.5017 after the company announced that it has repaid in full the outstanding balance on its secured promissory note with Streeterville Capital.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>DEFSEC Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFSC#NASDAQ">DFSC</a>) shares dropped 37% to $4.8970.</li>
<li>Shares of Sadot Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDOT#NASDAQ">SDOT</a>) were down 31% to $1.07 as the company announced the pricing of public offering.</li>
<li>Community Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) was down, falling 27% to $2.7850 following second-quarter results.</li>
</ul>
Commodities In commodity news, oil traded up 0.8% to $65.76 while gold traded down 0.9% at $3,367.60.
Silver traded down 0.8% to $39.185 on Thursday, while copper fell 0.1% to $5.8160.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.1%, while Spain's IBEX 35 Index rose 1.4%. London's FTSE 100 gained 0.8%, Germany's DAX 40 rose 0.1% and France's CAC 40 fell 0.6% during the session.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 surging 1.59%, Hong Kong's Hang Seng gaining 0.51%, China's Shanghai Composite gaining 0.65% and India's BSE Sensex falling 0.66%.
Economics
<ul class="wp-block-list">
<li>The S&amp;P Global manufacturing PMI declined to 49.5 in July, down from market estimates of 52.6.</li>
</ul>
<ul class="wp-block-list">
<li>U.S. initial jobless claims declined by 4,000 from the previous week to 217,000 in the third week of July, compared to market estimates of 227,000.</li>
<li>U.S. building permits fell by 0.1% to an annualized rate of 1.393 million in June.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46600695/alphabet-to-rally-around-24-here-are-10-top-analyst-forecasts-for-thursday">Alphabet To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Thursday</a></li>
</ul>
Photo via Shutterstock

Commodities

DEFSEC Technologies Inc. - common stock, no R/S concurrent with offering

DFSC

GSIW

TSLA

Dow Tumbles 300 Points; Tesla Posts Downbeat Q2 Results

U.S. stock futures were mixed this morning, with the Dow futures falling around 100 points on Thursday.
Shares of Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell sharply in pre-market trading as the company reported weaker-than-expected second-quarter financial results <a href="https://www.benzinga.com/markets/earnings/25/07/46587882/tesla-q2-earnings-highlights-revenue-and-earnings-fall-short-new-models-still-set-for-2025-2026">after market close Wednesday</a>.
Tesla reported second-quarter revenue of $22.5 billion, down 12% year-over-year. The revenue missed a Street consensus estimate of $22.8 billion according to data from Benzinga Pro. Tesla's earnings per share were $0.40 in the quarter, missing the Street consensus estimate of $0.42 per share.
Tesla shares dipped 6.5% to $310.99 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Community Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) dipped 21.9% to $3.03 in pre-market trading after the company posted second-quarter results.</li>
<li>Helix Energy Solutions Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLX#NYSE">HLX</a>) declined 14.1% to $5.97 in pre-market trading as the company posted downbeat second-quarter results and lowered its FY2025 sales guidance.</li>
<li>Galapagos NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLPG#NASDAQ">GLPG</a>) fell 13.4% to $28.78 in pre-market trading. Galapagos posted a second-quarter loss of $1.45 per share.</li>
<li>Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) fell 10.6% to $47.21 in pre-market trading after the company reported worse-than-expected quarterly sales results.</li>
<li>STMicroelectronics N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STM#NYSE">STM</a>) fell 10.3% to $28.52 in pre-market trading following downbeat quarterly earnings.</li>
<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) declined 7.4% to $30.93 in pre-market trading after the company reported worse-than-expected quarterly EPS results.</li>
<li>Krispy Kreme, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>) fell 6.3% to $4.0500 in pre-market trading following a 5% gain on Wednesday.</li>
<li>International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) fell 5.3% to $267.10 in pre-market trading following quarterly results.</li>
<li>QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) declined 4.8% to $12.18 in pre-market trading after posting second-quarter results.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46570034/jim-cramer-likes-stocks-yield-not-fundamentals">Jim Cramer Loves &#8216;That Yield&#8217; But Passes On This Stock: &#8216;Fundamentals Are Hurting&#8217;</a></li>
</ul>

Pre-Market Outlook

DNUT

GLPG

VKTX

Tesla Posts Downbeat Earnings, Joins Community Health Systems, Chipotle Mexican Grill And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) stock moved upwards by 72.8% to $24.2 during Thursday's pre-market session. The market value of their outstanding shares is at $22.1 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) stock rose 27.08% to $8.22. The company's market cap stands at $170.5 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock increased by 25.0% to $0.03. The company's market cap stands at $10.2 million. </li>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) stock rose 22.69% to $0.6. The market value of their outstanding shares is at $24.9 million. </li>
<li>West Pharmaceutical Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) stock moved upwards by 22.34% to $278.1. The company's market cap stands at $16.3 billion. As per the press release, Q2 earnings came out today. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCCP#NASDAQ">CYCCP</a>) shares increased by 16.12% to $5.4. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) shares declined by 30.4% to $2.7 during Thursday's pre-market session. The company's market cap stands at $544.3 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>Adagio Medical Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADGM#NASDAQ">ADGM</a>) shares declined by 19.21% to $1.43. The market value of their outstanding shares is at $27.2 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) stock decreased by 14.9% to $1.6. The market value of their outstanding shares is at $10.0 million. </li>
<li>Palisade Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) stock declined by 13.94% to $1.05. The company's market cap stands at $6.0 million. </li>
<li>Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) stock decreased by 10.6% to $0.52. The market value of their outstanding shares is at $45.4 million. </li>
<li>Hyperion DeFi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPD#NASDAQ">HYPD</a>) stock decreased by 9.88% to $8.4. The market value of their outstanding shares is at $47.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADGM

CLSD

CYCC

CYCCP

HYPD

PALI

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Barclays analyst Andrew Mok maintains Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) with a Equal-Weight and lowers the price target from $4 to $3.5.

Barclays Maintains Equal-Weight on Community Health Sys, Lowers Price Target to $3.5

Jefferies analyst Brian Tanquilut downgrades Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) from Buy to Hold and lowers the price target from $4.25 to $3.

Downgrades

Jefferies Downgrades Community Health Sys to Hold, Lowers Price Target to $3

Shares of Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results. The company increased its investment i<a href="https://www.benzinga.com/markets/earnings/25/07/46587283/alphabet-q2-earnings-revenue-eps-beat-estimates-google-parent-raises-capex-outlook-due-to-strong-and-growing-cloud-demand">n capital expenditures in 2025.</a>
Google parent Alphabet reported second-quarter revenue of $96.43 billion, beating analyst estimates of $93.72 billion. The company reported second-quarter earnings of $2.31 per share, beating estimates of $2.16 per share.
Alphabet jumped 3% to $196.00 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Garden Stage Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSIW#NASDAQ">GSIW</a>) shares jumped 58.1% to $0.2786 in pre-market trading after gaining 4% on Wednesday.</li>
<li>Oriental Rise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIS#NASDAQ">ORIS</a>) shares gained 41.3% to $0.2465 in pre-market trading after gaining around 9% on Wednesday.</li>
<li>Incannex Healthcare Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IXHL#NASDAQ">IXHL</a>) rose 37.6% to $1.39 in pre-market trading after jumping 20% on Wednesday.</li>
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) climbed 28.1% to $0.0326 in pre-market trading after gaining 33% on Wednesday.</li>
<li>MaxLinear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NASDAQ">MXL</a>) gained 22.3% to $18.78 in pre-market trading after the company reported better-than-expected second-quarter sales results and issued third-quarter sales guidance with its midpoint above estimates.</li>
<li>Erayak Power Solution Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAYA#NASDAQ">RAYA</a>) surged 21.2% to $0.2166 in pre-market trading.</li>
<li>Pixelworks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXLW#NASDAQ">PXLW</a>) surged 16.1% to $14.70 in pre-market trading after jumping 20% on Wednesday.</li>
<li>ICON Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) gained 16.7% to $196.00 in pre-market trading after the company reported better-than-expected second-quarter financial results and raised its FY25 sales guidance.</li>
<li>American Eagle Outfitters, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) rose 14.6% to $12.40 in pre-market trading following the launch of a new advertising campaign featuring actress Sydney Sweeney. The surge adds to speculation that the apparel retailer could become the latest target in the ongoing meme stock phenomenon.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Sadot Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDOT#NASDAQ">SDOT</a>) dipped 29.5% to $1.10 in pre-market trading as the company announced the pricing of public offering.</li>
<li>Community Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) dipped 21.9% to $3.03 in pre-market trading after the company posted second-quarter results.</li>
<li>Helix Energy Solutions Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLX#NYSE">HLX</a>) declined 14.1% to $5.97 in pre-market trading as the company posted downbeat second-quarter results and lowered its FY2025 sales guidance.</li>
<li>Pineapple Financial Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAPL#NASDAQ">PAPL</a>) declined 13.5% to $5.15 in pre-market trading after gaining 70% on Wednesday.</li>
<li>Galapagos NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLPG#NASDAQ">GLPG</a>) fell 13.4% to $28.78 in pre-market trading. Galapagos posted a second-quarter loss of $1.45 per share.</li>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) shares tumbled 13% to $0.14 in pre-market trading after gaining 43% on Wednesday.</li>
<li>Palisade Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) fell 12.3% to $1.07 in pre-market trading after the company announced exercise of previously issued warrants for $3.9 million.</li>
<li>Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) fell 10.6% to $47.21 in pre-market trading after the company reported worse-than-expected quarterly sales results.</li>
<li>STMicroelectronics N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STM#NYSE">STM</a>) fell 10.3% to $28.52 in pre-market trading following downbeat quarterly earnings.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares fell 6.5% to $310.99 in pre-market trading as the company reported weaker-than-expected second-quarter financial results after market close Wednesday.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46570034/jim-cramer-likes-stocks-yield-not-fundamentals"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46570034/jim-cramer-likes-stocks-yield-not-fundamentals">Jim Cramer Loves &#8216;That Yield&#8217; But Passes On This Stock: &#8216;Fundamentals Are Hurting&#8217;</a></li>
</ul>
Photo via Shutterstock

FOXO

ICLR

IXHL

ORIS

PAPL

PXLW

RAYA

Why Alphabet Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Management

Community Health Systems Kevin Hammons To Become Interim CEO;  Intent To Appoint Jason Johnson As Interim CFO

<h3>Gainers</h3>
<ul>
<li>Aprea Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APRE#NASDAQ">APRE</a>) stock moved upwards by 8.3% to $2.09 during Wednesday's after-market session. The company's market cap stands at $11.5 million. </li>
<li>Y-mAbs Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YMAB#NASDAQ">YMAB</a>) shares rose 8.1% to $5.2. The market value of their outstanding shares is at $199.7 million. </li>
<li>HeartSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSCS#NASDAQ">HSCS</a>) stock rose 7.18% to $4.03. The company's market cap stands at $6.0 million. </li>
<li>Aditxt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTX#NASDAQ">ADTX</a>) stock increased by 4.87% to $1.29. The company's market cap stands at $3.0 million. </li>
<li>Iterum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRM#NASDAQ">ITRM</a>) shares rose 4.56% to $0.87. The company's market cap stands at $33.2 million. </li>
<li>Cabaletta Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CABA#NASDAQ">CABA</a>) shares increased by 4.37% to $1.67. The market value of their outstanding shares is at $142.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) shares decreased by 16.2% to $3.25 during Wednesday's after-market session. The company's market cap stands at $538.7 million. The company's, Q2 earnings came out today. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) shares declined by 8.66% to $0.27. The company's market cap stands at $13.4 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares decreased by 7.98% to $1.73. The market value of their outstanding shares is at $7.7 million. </li>
<li>Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) shares declined by 7.19% to $31.0. The company's market cap stands at $3.6 billion. As per the news, the Q2 earnings report came out today. </li>
<li>CASI Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASI#NASDAQ">CASI</a>) shares declined by 6.45% to $1.28. The market value of their outstanding shares is at $19.4 million. </li>
<li>Artiva Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTV#NASDAQ">ARTV</a>) shares declined by 5.78% to $3.02. The market value of their outstanding shares is at $62.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADTX

APRE

ARTV

CABA

CASI

HSCS

ITRM

YMAB

12 Health Care Stocks Moving In Wednesday's After-Market Session

Community Health Systems shares are trading lower following Q2 reported financial results.

Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) is looking for FY2025 GAAP EPS of $(0.40)-$(0.10) vs $(0.75) analyst estimate. Raises FY2025 sales outlook from $12.200 billion-$12.600 billion to $12.300 billion-$12.600 billion vs $12.374 billion estimate.

Guidance

Community Health Sys Sees FY2025 GAAP EPS $(0.40)-$(0.10) vs $(0.75) Est; Raises FY2025 Sales Guidance from $12.200B-$12.600B to $12.300B-$12.600B vs $12.374B Est

Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.09) by 43.82 percent. This is a 70.59 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $3.133 billion which beat the analyst consensus estimate of $3.020 billion by 3.74 percent. This is a 0.22 percent decrease over sales of $3.140 billion the same period last year.

Earnings Beats

Community Health Sys Q2 Adj. EPS $(0.05) Beats $(0.09) Estimate, Sales $3.133B Beat $3.020B Estimate

Community Health Systems CEO Tim Hingtgen  To Resign; Kevin Hammons Appointed Interim CEO

AMTB

ASGN

BANC

BPOP

BRKL

CADE

CBAN

CHDN

COOP

CSBR

CVBF

CVLG

EGBN

EPRT

EQNR

ESRT

First Trust Advantage Preferred Income Fund

FRME

FSBC

GSHD

HBNC

HCSG

INBK

KALU

MTAL

NTRS

NTST

NVEC

ORLY

OTIS

OTLY

OXLC

PLXS

PTEN

QCRH

RBBN

RELL

SEIC

SIGI

Earnings Scheduled For July 23, 2025

Community Health Systems, Inc. (Company) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a definitive agreement with Labcorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>), pursuant to which Labcorp will acquire select assets and assume certain leases of the ambulatory outreach laboratory services of CHS health systems in 13 states, including certain patient service centers and in-office phlebotomy locations, for $195 million cash.
When the transaction is complete, CHS patients and providers will benefit from broader access to Labcorp's comprehensive testing and laboratory services, including its specialty testing menu, robust data analytics and digital tools. CHS health systems will continue to operate their inpatient and emergency department laboratories and will continue to provide laboratory services for hospital-based services, such as imaging and pre-admission testing.
"We are excited about this transaction with Labcorp, which allows us to focus on our core services and improve the overall patient experience, aligning with our unwavering commitment to providing high-quality, accessible healthcare to our communities," said Kevin Stockton, Executive Vice President, Operations and Development for CHS. "Labcorp's scale and investment in technology supports its ability to efficiently deliver outreach laboratory services to patients and healthcare consumers."
"Labcorp and Community Health Systems share a deep commitment to improving the health and lives of the communities we serve, and our goal with this agreement is to enhance the patient and provider experience with increased access to high-quality laboratory services," added Mark Schroeder, EVP and President, Diagnostics Laboratories and Chief Operations Officer, Labcorp. "This acquisition will allow us to leverage the strengths of both our organizations to positively impact healthcare for communities across the U.S."
The organizations are committed to working together to plan and implement a smooth, thoughtful transition that maintains continuity of services for patients, hospitals, clinicians and clients, while providing direct access to the additional capabilities of Labcorp.
This relationship is similar to other strategic relationships that Labcorp has with a range of local and regional health systems that have enhanced services for patients and providers.
The transaction is subject to customary closing conditions and applicable regulatory approvals. The companies anticipate closing the transaction in the fourth quarter of 2025. Until that time, there will be no changes in operations or services.

General

Laboratory Corporation Of America Holdings

Community Health Systems' Subsidiary, CHS/Community Health Systems, And Labcorp Enter Into A Definitive Agreement; Labcorp To Acquire Select Assets And Assume Certain Leases Of The Ambulatory Outreach Laboratory Services Of CHS Health Systems In 13 States For $195M In Cash

Truist Securities analyst David Macdonald maintains Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) with a Hold and raises the price target from $3.5 to $4.25.

Truist Securities Maintains Hold on Community Health Sys, Raises Price Target to $4.25

Press Releases

Community Health Systems, Inc. Announces First Quarter Ended March 31, 2025 Results

Community Health Systems, Inc. Announces Sale of $700 Million Aggregate Principal Amount of 10.750% Senior Secured Notes Due 2033

Community Health Systems, Inc. Announces Commencement of Cash Tender Offer for 6.875% Senior Unsecured Notes Due 2028

Community Health Systems, Inc. Announces Early Tender Results of Previously Announced Tender Offer for 6.875% Senior Unsecured Notes Due 2028

Community Health Systems to Participate in 2025 RBC Capital Markets Global Healthcare Conference

Community Health Systems Completes Divestiture of Cedar Park Regional Medical Center in Texas

Community Health Systems to Webcast Second Quarter 2025 Conference Call

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

Community Health Systems, Inc. Announces Second Quarter Ended June 30, 2025 Results

Comments

Community Health Sys

Intérêt court

Community Health Sys (NYSE:CYH) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL